Trends in the prevalence and management of atrial fibrillation in general practice in England and Wales, 1994-1998: analysis of data from the general practice research database

被引:196
作者
Majeed, A
Moser, K
Carroll, K
机构
[1] Off Natl Stat, London SW1V 2QQ, England
[2] UCL, Sch Publ Policy, London WC1H 9EZ, England
关键词
atrial fibrillation; prevalence; treatment; primary care;
D O I
10.1136/heart.86.3.284
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective-To determine the prevalence of atrial fibrillation in England and Wales, and examine trends in its treatment with warfarin and aspirin between 1994 and 1998. Design-Analysis of data from the general practice research database. Setting-England and Wales. Patients-1.4 million patients registered with 211 general practices. Main outcome measures-Age and sex specific prevalence rates of atrial fibrillation; percentage of patients with atrial fibrillation treated with oral anticoagulants or aspirin. Results-The prevalence of atrial fibrillation in 1998 was 12.1/1000 in men and 12.7/1000 in women. Prevalence increased from less than 1/1000 in under 35 year olds to over 100/1000 in those aged 85 years and over. There was a 22% increase in the age standardised prevalence of atrial fibrillation in men and a 14% increase in women between 1994 and 1998. The percentage of patients prescribed oral anticoagulants increased from 20% to 34% in men and from 17% to 25%, in women. The percentage of men with atrial fibrillation prescribed aspirin increased from 26% to 36%. and the percentage of women increased from 24% to 36%. Applying the age and sex specific prevalence and treatment rates to the population gives an estimate of around 650 000 cases of atrial fibrillation in England and Wales. The greatest number of cases occurs in the 75-84 year old age group. Conclusions-The number of patients in the community with identified atrial fibrillation is increasing. There has also been a pronounced increase in the percentage of patients with atrial fibrillation prescribed oral anticoagulants or aspirin.
引用
收藏
页码:284 / 288
页数:5
相关论文
共 23 条
[1]  
ASINGER RW, 1989, ARCH NEUROL-CHICAGO, V46, P727
[2]  
Carrol K, 2001, HLTH STAT Q, V9, P37
[3]  
Department of Health, 2000, NAT SERV FRAM COR HE
[4]   Atrial fibrillation: The epidemic of the new millennium [J].
Ezekowitz, MD .
ANNALS OF INTERNAL MEDICINE, 1999, 131 (07) :537-538
[5]   PREVALENCE OF ATRIAL-FIBRILLATION IN ELDERLY SUBJECTS (THE CARDIOVASCULAR HEALTH STUDY) [J].
FURBERG, CD ;
PSATY, BM ;
MANOLIO, TA ;
GARDIN, JM ;
SMITH, VE ;
RAUTAHARJU, PM .
AMERICAN JOURNAL OF CARDIOLOGY, 1994, 74 (03) :236-241
[6]   Warfarin use among ambulatory patients with nonvalvular atrial fibrillation: The AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) study [J].
Go, AS ;
Hylek, EM ;
Borowsky, LH ;
Phillips, KA ;
Selby, JV ;
Singer, DE .
ANNALS OF INTERNAL MEDICINE, 1999, 131 (12) :927-+
[7]   Stroke with intermittent atrial fibrillation: Incidence and predictors during aspirin therapy [J].
Hart, RG ;
Pearce, LA ;
Rothbart, RM ;
McAnulty, JH ;
Asinger, RW ;
Halperin, JL .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2000, 35 (01) :183-187
[8]   Antithrombotic therapy to prevent stroke in patients with atrial fibrillation: A meta-analysis [J].
Hart, RG ;
Benavente, O ;
McBride, R ;
Pearce, LA .
ANNALS OF INTERNAL MEDICINE, 1999, 131 (07) :492-+
[9]  
HILL JD, 1987, J ROY COLL GEN PRACT, V37, P172
[10]  
Hollowell J, 1997, Popul Trends, P36